Nymox Pharmaceutical
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. The net income raised on -$6,571,000 over the previous period. Total operating expenses were $6,652,000.
Profit Margin
| 2013 | 3.35M | -4.90M | -146.13% |
|---|---|---|---|
| 2014 | 2.94M | -4.59M | -155.76% |
| 2015 | 2.76M | -17.89M | -648.03% |
| 2016 | 283.61K | -13.10M | -4622.39% |
| 2017 | 224K | -13.42M | -5995.09% |
| 2018 | 299K | -10.59M | -3543.14% |
| 2019 | 116K | -13.2M | -11379.31% |
| 2020 | 5K | -11.78M | -235600% |
| 2021 | 0 | -12.57M | |
| 2022 | 0 | -6.57M |
NYMX Income Statement (2013 – 2022)
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||
Revenue | 0 | 0 | 5K | 116K | 299K | 224K | 283.61K | 2.76M | 2.94M | 3.35M |
Cost of revenue | 0 | 0 | 4K | 58K | 138K | 149K | 173.02K | 160.31K | 173.66K | 486.15K |
Gross profit | 0 | 0 | 1K | 58K | 161K | 75K | 110.58K | 2.60M | 2.77M | 2.87M |
Operating exp. | ||||||||||
Research and development | 3.77M | 6.65M | 8.12M | 7.37M | 6.67M | 7.87M | 6.79M | 8.64M | 4.76M | 6.27M |
Selling and marketing | 0 | 0 | 0 | 0 | 0 | 8K | 6.75K | 9.52K | 186.61K | 282.05K |
Total operating expenses | 6.65M | 12.50M | 11.72M | 13.38M | 10.80M | 13.31M | 12.97M | 20.26M | 7.50M | 7.75M |
Operating income | -6.65M | -12.50M | -11.72M | -13.32M | -10.64M | -13.23M | -12.86M | -17.66M | -4.72M | -4.88M |
Other income (expenses), net | 76K | -33K | -18K | 163K | -7K | -194K | -10.14K | -233.55K | 78.61K | -18.19K |
Income before tax | -6.57M | -12.53M | -11.73M | -13.16M | -10.59M | -13.42M | -13.10M | -17.89M | -4.64M | -4.90M |
Income tax expense | -5K | 39K | 42K | 38K | -47K | 204K | 233.79K | 187.79K | -52K | 8.85K |
Net income | -6.57M | -12.57M | -11.78M | -13.2M | -10.59M | -13.42M | -13.10M | -17.89M | -4.59M | -4.90M |
Earnings per share | ||||||||||
Basic EPS | -0.07 | -0.15 | -0.16 | -0.19 | -0.18 | -0.26 | -0.28 | -0.48 | -0.13 | -0.14 |
Diluted EPS | -0.07 | -0.15 | -0.16 | -0.19 | -0.18 | -0.26 | -0.28 | -0.48 | -0.13 | -0.14 |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |